STAT3 and cancer: Of note, in cancers associated with gammaherpesviruses, both NRF2 inhibition and NRF2 activation may represent a promising therapeutic approach, as ROS, unless they are too high, can sustain pro-survival, oncogenic pathways, such as STAT3 [32,98,99,100,101].